OXOS key facts
as of Oct 2026- Developer of a digital imaging device designed for efficient and effective treatment of patients.
- OXOS is valued at approximately $139.0M as of Oct 2026 (last reported valuation).
- It has raised $56.7M; the latest was Later Stage VC ($10.7M) in Dec 2025.
- Notable investors include Sequoia Capital, MedTech Innovator, Intel Capital, Parkway Venture Capital, FedTech — 11 tracked in total.
- Status: Privately Held (backing).
OXOS's last reported valuation, Apr 2023. Nothing priced has surfaced since.
- ·The complete investor list: 11 names
- ·Watch OXOS: the Monday email on marks, rounds and moves
OXOS funding rounds
No funding rounds for OXOS are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs OXOS
11+OXOS valuation
OXOS's last reported valuation was $139 million in Apr 2023. No priced round, secondary trade or fund mark has surfaced since.
OXOS investors
11 investors are on record for OXOS, including Sequoia Capital, MedTech Innovator, Intel Capital and Parkway Venture Capital.
About OXOS
Developer of a digital imaging device designed for efficient and effective treatment of patients. The company's devices are fluoroscopic instruments used to convert radiation to real-time static and dynamic fluoroscopic images of the human skeleton, as well as provide high-quality digital pictures and video of surgical anatomy and pathology, enabling surgeons, doctors and healthcare providers to bring the x-ray source to the target to produce more resolute images.
- Sector
- Healthcare
- HQ
- Atlanta, GA, United States
- Founded
- 2016
- Employees
- 70
- Website
- oxos.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.